Liang, J., Wang, L., Wang, X., Cui, G., Zhou, J., Xing, T., . . . Hao, X. (2024). Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma. Chinese Medical Journal, 137(13), 1576-1582. https://doi.org/10.1097/CM9.0000000000002836
Chicago-referens (17:e uppl.)Liang, Jinhua, et al. "Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide for Relapsed or Refractory Peripheral T-cell Lymphoma." Chinese Medical Journal 137, no. 13 (2024): 1576-1582. https://doi.org/10.1097/CM9.0000000000002836.
MLA-referens (9:e uppl.)Liang, Jinhua, et al. "Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide for Relapsed or Refractory Peripheral T-cell Lymphoma." Chinese Medical Journal, vol. 137, no. 13, 2024, pp. 1576-1582, https://doi.org/10.1097/CM9.0000000000002836.
